Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
clinical trials
2
×
fda
life sciences
national blog main
acute hepatic porphyrias
akin akinc
alnylam pharmaceuticals
alprazolam
amgen
aminolevulinic acid
biotech
boston
boston top stories
cgrp inhibitors
chronic migraine
colucid pharmaceuticals
drug enforcement administration
drugs
eli lilly
givosiran
indiana
indiana blog main
indiana top stories
lasmiditan
migraine research foundation
onpattro
patisiran
paul matteis
raleigh-durham blog main
raleigh-durham top stories
rna interference
stifel financial
teva pharmaceutical
triptans
What
approval
2
×
drug
fda
second
2
×
acute
addresses
ago
alnylam
causes
condition
decades
eli
friday
giant
giving
indicated
interference
lasmiditan
lilly
lilly’s
medication
medicine
migraine
new
nod
oks
pharmaceutical
pharmaceuticals
quick
rna
rnai
seek
speedy
weeks
won
won’t
Language
unset
Current search:
approval
×
" clinical trials "
×
second
×
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug